Breast MRI
Find your care
We offer the full breadth of services to screen for and diagnose breast cancer. To learn more about breast imaging services, call
.Recommendations for Breast MRI Screening as an Adjunct to Mammography
Recommend Annual MRI Screening (Based on Evidence*)
- BRCA mutation
- First-degree relative of BRCA carrier, but untested
- Lifetime risk ~20-25% or greater, as defined by BRCAPRO or other models that are largely dependent on family history
Recommend Annual MRI Screening (Based on Expert Consensus Opinion**)
- Radiation to chest between age 10 and 30 years
- Li-Fraumeni syndrome and first-degree relatives
- Cowden and Bannayan-Riley-Ruvalcaba syndromes and first-degree relatives
Insufficient Evidence to Recommend for or Against MRI Screening***
- Lifetime risk 15-20%, as defined by BRCAPRO or other models that are largely dependent on family history
- Lobular carcinoma in situ (LCIS) or atypical lobular hyperplasia (ALH)
- Atypical ductal hyperplasia (ADH)
- Heterogeneously or extremely dense breast on mammography
- Women with a personal history of breast cancer, including ductal carcinoma in situ (DCIS)
Recommend Against MRI Screening (Based on Expert Consensus Opinion)
- Women at <15% lifetime risk
- * Evidence from nonrandomized screening trials and observational studies.
- ** Based on evidence of lifetime risk for breast cancer.
- *** Payment should not be a barrier. Screening decisions should be made on a case-by-case basis, as there may be particular factors to support MRI. More data on these groups is expected to be published soon.